Sponsored by:
Impact Assessment of eClinical Technologies and Industry Initiatives on Sites
Sponsors and contract research organizations (CROs) fight a continuous uphill battle to reduce complexity, streamline business processes and workflows, ensure compliance and increase efficiencies in the pursuit of bringing drugs to market. Fundamental to this goal is a site-centric approach to conducting clinical trials.
Sites are dynamic environments, and new technology and industry initiatives are important complements to the critical need for relationship-building and maintenance. But, are these technologies and initiatives helping improve site and sponsor-CRO collaboration and creating a competitive edge through improved clinical trial performance?
To explore these issues and their impact, the Society for Clinical Research Sites (SCRS) and Oracle Health Sciences surveyed clinical research site professionals around the world.
Key findings from the research:
- Increasingly negative sentiment toward disparate systems
- Single sign-on and point of entry cited as priorities
- Competition among sites for studies is prompting sites to improve their profile and improve their chances of being selected
- Opportunities and challenges lay ahead as the industry moves from traditional to hybrid studies
Download our research report to learn more.
About Oracle Health Sciences
As a leader in Life Sciences cloud technology, Oracle Health Sciences’ Clinical One and Safety One are trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance. With over 20 years’ experience, Oracle Health Sciences is committed to supporting clinical development, delivering innovation to accelerate advancements, and empowering the Life Sciences industry to improve patient outcomes. Oracle Health Sciences. For life.
